AVTE
Price
$2.49
Change
-$0.02 (-0.80%)
Updated
Apr 4, 04:58 PM (EDT)
Capitalization
73.04M
45 days until earnings call
NTLA
Price
$6.63
Change
-$0.26 (-3.77%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
712.2M
27 days until earnings call
Ad is loading...

AVTE vs NTLA

Header iconAVTE vs NTLA Comparison
Open Charts AVTE vs NTLABanner chart's image
Aerovate Therapeutics
Price$2.49
Change-$0.02 (-0.80%)
Volume$538
Capitalization73.04M
Intellia Therapeutics
Price$6.63
Change-$0.26 (-3.77%)
Volume$82.29K
Capitalization712.2M
AVTE vs NTLA Comparison Chart
Loading...
AVTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVTE vs. NTLA commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVTE is a StrongBuy and NTLA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (AVTE: $2.51 vs. NTLA: $6.89)
Brand notoriety: AVTE and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVTE: 110% vs. NTLA: 114%
Market capitalization -- AVTE: $73.04M vs. NTLA: $712.2M
AVTE [@Biotechnology] is valued at $73.04M. NTLA’s [@Biotechnology] market capitalization is $712.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVTE’s FA Score shows that 1 FA rating(s) are green whileNTLA’s FA Score has 1 green FA rating(s).

  • AVTE’s FA Score: 1 green, 4 red.
  • NTLA’s FA Score: 1 green, 4 red.
According to our system of comparison, AVTE is a better buy in the long-term than NTLA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVTE’s TA Score shows that 6 TA indicator(s) are bullish while NTLA’s TA Score has 4 bullish TA indicator(s).

  • AVTE’s TA Score: 6 bullish, 4 bearish.
  • NTLA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AVTE is a better buy in the short-term than NTLA.

Price Growth

AVTE (@Biotechnology) experienced а -0.79% price change this week, while NTLA (@Biotechnology) price change was -17.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.31%. For the same industry, the average monthly price growth was -17.16%, and the average quarterly price growth was -18.95%.

Reported Earning Dates

AVTE is expected to report earnings on May 19, 2025.

NTLA is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-11.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($712M) has a higher market cap than AVTE($73M). AVTE YTD gains are higher at: -5.283 vs. NTLA (-40.909). AVTE has higher annual earnings (EBITDA): -89.96M vs. NTLA (-523.98M). NTLA has more cash in the bank: 602M vs. AVTE (88.7M). AVTE has less debt than NTLA: AVTE (540K) vs NTLA (210M). NTLA has higher revenues than AVTE: NTLA (57.9M) vs AVTE (0).
AVTENTLAAVTE / NTLA
Capitalization73M712M10%
EBITDA-89.96M-523.98M17%
Gain YTD-5.283-40.90913%
P/E RatioN/AN/A-
Revenue057.9M-
Total Cash88.7M602M15%
Total Debt540K210M0%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVTENTLA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 12 days ago
79%
Declines
ODDS (%)
Bearish Trend 23 days ago
90%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
AVTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MAICX8.47N/A
N/A
Victory Trivalent Intl Fd-Core Eq A
OMGNX53.74N/A
N/A
Invesco Main Street R
MYIFX18.23N/A
N/A
Monetta Young Investor Growth
LGASX60.84N/A
N/A
ClearBridge Small Cap FI
PSBMX23.69N/A
N/A
Principal SmallCap R3

AVTE and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVTE has been closely correlated with OVID. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if AVTE jumps, then OVID could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVTE
1D Price
Change %
AVTE100%
-0.40%
OVID - AVTE
89%
Closely correlated
-11.35%
NTLA - AVTE
46%
Loosely correlated
-5.62%
DNLI - AVTE
43%
Loosely correlated
-6.91%
BEAM - AVTE
41%
Loosely correlated
-10.93%
SNDX - AVTE
39%
Loosely correlated
-3.93%
More

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with VCYT. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
-5.62%
VCYT - NTLA
69%
Closely correlated
-5.51%
CRSP - NTLA
64%
Loosely correlated
-4.47%
BEAM - NTLA
62%
Loosely correlated
-10.93%
RXRX - NTLA
59%
Loosely correlated
-9.07%
ABCL - NTLA
57%
Loosely correlated
-5.86%
More